跳至主要内容
临床试验/NCT00230672
NCT00230672已完成不适用

Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients

Imperial College London1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2005年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1
试验地点
1

研究概览

简要总结

Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels, including arteriovenous malformations in the lungs (PAVMs). We hypothesize that the genetically-determined abnormality in the blood vessels of HHT patients leads to alteration in the concentrations or activity of several proteins in the blood stream. We propose to take blood samples from patients at defined times in order to study changes in blood protein levels and activity

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations -

排除标准

  • Unable to provide informed consent

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Investigation of Plasma Proteins in Patients With... | 临床试验